Skip to main content
logo
Active Biotech AB (publ) (STO:ACTI)
Sweden flag Sweden · Delayed Price · Currency is SEK
5.07
+0.02 (0.40%)
Sep 2, 2026, 5:29 PM CET

Active Biotech AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-34.1-37.6-39.84-46.48-57.89-49.78
Net Income
-33.52-37.32-39.4-45.8-58.37-49.83
Earnings Per Share
-1.79-3.00-9.37-17.00-25.00-23.29
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
43.965.127.436.2241.853.13
Total Debt
0.11.743.184.556.040.99
Net Cash (Debt)
43.863.3624.2131.6735.7652.15
Net Cash Growth
173.75%161.72%-23.56%-11.42%-31.43%115.38%
Net Cash Per Share
2.144.705.7611.6615.3024.38

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-31.4-32.4-40.42-45.74-54.85-46.17
Free Cash Flow
-31.4-32.4-40.42-45.74-54.85-46.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-103.10103.10103.10103.10103.10
PS Ratio
------